ClinicalTrials.gg
CompletedNCT07419685Updated Feb 19, 2026

Intraoral Appliance (IOA) Model Evaluating the Efficacy of a Whitening Toothpaste

An interventional study of Negative Control Toothpaste and Active Comparator in Dental Caries, sponsored by Church & Dwight Company, Inc.. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Church & Dwight Company, Inc. · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Oct 2024, registered Feb 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 194 studies in Dental Caries with a site in United States — 17 open to participants now, 20 under way, 3 of them phase 3. Dental Caries · United States.

Enrollment
126th of 169
31 · median 60
Started
2024
with 9 others
No phase
111 of 194
14 open now
Registered
188th of 194
by date

Among the 194 studies in Dental Caries with a site in United States, this one is the 126th largest by enrollment of the 169 interventional ones that give a count, is one of 10 that started in 2024, is one of 111 with no phase, and was the 188th registered.

Dental Caries

1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

Browse Dental Caries studies →

Open to participants now

17 of the 194 studies in Dental Caries with a site in United States are open now. Recruiting first, the newest first:

12 more — sign in →

All 17 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 194 studies in Dental Caries with a site in United States, or all of them as a file.
02

Study summary

This single-center, randomized, double-blind, three-period crossover in situ study evaluated the enamel remineralization potential and fluoride bioavailability of three dentifrices-one fluoride-free negative control, one positive control with 0.243% sodium fluoride, and one investigational dentifrice containing 0.243% sodium fluoride and 20% sodium bicarbonate. Healthy adult subjects wore a palatal acrylic appliance containing demineralized enamel specimens for three 9-day treatment periods, during which in vivo brushing/slurry exposure and ex vivo sucrose challenges were performed. Outcomes included percent surface microhardness recovery (%SMHR) and post-treatment enamel fluoride concentration.

Read the detailed description

This in situ intraoral appliance (IOA) model evaluates anticaries potential by exposing demineralized enamel specimens to oral conditions while allowing for ex vivo treatment assessments. Subjects wore acrylic palatal appliances containing four enamel specimens covered with steel gauze to promote plaque formation. Each of the three treatment periods lasted nine days and included twice-daily toothbrushing and dentifrice slurry swishing, plus three daily sucrose challenges. A minimum 4-day fluoride-free washout preceded each period. Post-treatment specimens were analyzed for %SMHR and enamel fluoride concentration.

03

Conditions studied

  • Dental Caries

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults ≥18 years
  • Good general and oral health
  • Normal unstimulated salivary flow (≥1.5 mL/5 min)
  • Functional dentition
  • Oral conditions adequate to support the palatal appliance
  • Ability to comply with brushing, slurry, appliance wear, and sucrose challenge procedures

Exclusion criteria

Exclusion Criteria:

  • Inability to tolerate appliance
  • Oral pathology that interferes with participation
  • Antibiotic use that violates withdrawal criteria
  • Use of fluoride toothpaste during washout
  • Participation in another appliance study in the past 4 weeks
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
31 participants (actual)

Study arms

  • Placebo comparator
    Negative Control Toothpaste

    Fluoride-free dentifrice (0 ppm fluoride). Used for twice-daily brushing and slurry swishing during each test day.

    Drug: Negative Control Toothpaste

  • Active comparator
    Comparator

    Drug: Active Comparator

  • Experimental
    Test Toothpaste

    Drug: Test Toothpaste

Interventions

  • DrugNegative Control Toothpaste

    Fluoride-free toothpaste

  • DrugActive Comparator

    Commercially available fluoride toothpaste

  • DrugTest Toothpaste

    lnvestigational fluoride toothpaste

06

What researchers measure

Primary outcomes

  1. Percent Surface Microhardness Recovery (%SMHR) [Time Frame: End of each 9-day test period (three test periods in total)]

    Time frame: End of each 9#day test period (three test periods in total)

  2. Post-treatment fluoride concentration (µg F/g enamel)

    Time frame: End of each 9-day test period (three test periods in total

07

Study locations

1 site
  • Therametric Technologies, Inc.
    Noblesville, Indiana 46060, United States
08

References and documents

Individual participant data

Plan to share: No — The sponsor does not plan to share individual participant data (IPD) from this study. Summary results will be provided as required, but no de-identified datasets or additional supporting documents will be made available.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Jan 2025, 3 months.

Of 33 industry-sponsored interventional studies with no phase under Dental Caries, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 24. This study's 3 months is below that.

Counting every sponsor, half of 502 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2026
First posted
Feb 19, 2026
StartActual
Oct 8, 2024
Primary completionActual
Jan 17, 2025
CompletionActual
Jan 17, 2025
Last update
Feb 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07419685
Responsible party
Sponsor
First posted
Feb 19, 2026
Start date
Oct 8, 2024
Primary completion
Jan 17, 2025
Completion
Jan 17, 2025
Last update
Feb 19, 2026

Study contacts

Annahita Ghassemi, PhD
study director · Church & Dwight, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion